| European Case Law Identifier: | ECLI:EP:BA:2017:T125916.20170912 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 12 September 2017 | ||||||||
| Case number: | T 1259/16 | ||||||||
| Application number: | 10194363.7 | ||||||||
| IPC class: | C07K 1/00 C07K 1/14 C07K 14/00 C08G 69/10 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | D | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Process for the preparation of mixtures of trifluoroacetyl glatiramer acetate using purified hydrobromic acid | ||||||||
| Applicant name: | Teva Pharmaceutical Industries Ltd. | ||||||||
| Opponent name: | Generics [UK] Ltd (trading as Mylan) Actavis Group ehf (opposition withdrawn) Synthon BV Hexal AG G. L. Pharma GmbH (Intervener) |
||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Main request, auxiliary requests 1 to 32: amendments - allowable (no) Auxiliary requests 33 to 35: admitted (no) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t161259eu1.html
Date retrieved: 17 May 2021